We first described SP-NK1R system in the Hep-2 laryngeal carcinoma cell line and demonstrated that NK1R activation, mediated by SP, induced the growth of human laryngeal cancer cells [65]. The gene discussed is TACR1; the disease is laryngeal carcinoma.